Table 2.
Prevalence of diabetes, IFG and normoglycemia in PURE Poland Study population in baseline, 3-year and 6-year follow-up
| Baseline | p-value | Follow-up 3 | p-value | Follow-up 6 | p-value | |
|---|---|---|---|---|---|---|
| Diabetes prevalence | ||||||
| Total | 235 (17,67%) | 319 (23,98%) | 376 (28,27%) | |||
| Female | 133 (15,85%) | 0.02 | 175 (20,86%) | < 0.01 | 204 (24,31%) | < 0.01 |
| Male | 102 (20,77%) | 144 (29,33%) | 172 (35,03%) | |||
| Urban | 105 (12,68%) | < 0.01 | 150 (18,12%) | < 0.01 | 182 (21,98%) | < 0.01 |
| Rural | 130 (25,9%) | 169 (33,67%) | 194 (38,65%) | |||
| IFG prevalence | ||||||
| Total | 345 (25.94%) | 288 (21.65%) | 229 (17.22%) | |||
| Female | 226 (26.94%) | > 0.05 | 157 (18.71%) | < 0.01 | 141 (16.81%) | > 0.05 |
| Male | 119 (24.24%) | 131 (26.68%) | 88 (17.92%) | |||
| Urban | 186 (22.46%) | < 0.01 | 121 (14.61%) | < 0.01 | 124 (14.98%) | < 0.01 |
| Rural | 159 (31.67%) | 167 (33.07%) | 105 (20.92%) | |||
| Normoglycemia prevalence | ||||||
| Total | 750 (56.39%) | 723 (54.36%) | 725 (54.51%) | |||
| Female | 480 (57.21%) | > 0.05 | 507 (60.43%) | < 0.01 | 494 (58.88%) | < 0.01 |
| Male | 270 (54.99%) | 216 (43.99%) | 231 (47.05%) | |||
| Urban | 537 (64.86%) | < 0.01 | 557 (67.27%) | < 0.01 | 522 (63.04%) | < 0.01 |
| Rural | 213 (42.43%) | 166 (33.07%) | 203 (40.44%) | |||